menu
    • menu

    Company profile for Surrozen

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Through selective activation of the Wnt pathway with targeted antibodies, Surrozen is pioneering a new class of therapeutics to treat serious diseases characterized by tissue injury. Surrozen is pioneering a new class of targeted regenerative antibodies to repair a broad range of tissues and restore organs damaged by serious disease. By designing tissue-specific antibodies that engage the body’s own biological repair mechan...
    Through selective activation of the Wnt pathway with targeted antibodies, Surrozen is pioneering a new class of therapeutics to treat serious diseases characterized by tissue injury. Surrozen is pioneering a new class of targeted regenerative antibodies to repair a broad range of tissues and restore organs damaged by serious disease. By designing tissue-specific antibodies that engage the body’s own biological repair mechanisms, we are developing a broad pipeline of first in class drug candidates to help patients across multiple disease areas of high unmet need.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    SurrozenUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    171 Oyster Point Blvd South San Francisco, California 94080
    Telephone
    Telephone
    650-475-2820
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.surrozen.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/surrozen/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Surrozen To Present At Upcoming Healthcare Investor Conferences
    Surrozen To Present At Upcoming Healthcare Investor Conferences

    25 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/25/3194706/0/en/Surrozen-to-Present-at-Upcoming-Healthcare-Investor-Conferences.html

    GLOBENEWSWIRE
    25 Nov 2025
    Share Share
    Surrozen Grants Inducement Under Nasdaq LR 5635(C)(4)
    Surrozen Grants Inducement Under Nasdaq LR 5635(C)(4)

    12 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/12/3186881/0/en/Surrozen-Reports-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    12 Nov 2025
    Share Share
    Surrozen Reports Q3 2025 Financial Results & Business Update
    Surrozen Reports Q3 2025 Financial Results & Business Update

    07 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/07/3183957/0/en/Surrozen-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Business-Update.html

    GLOBENEWSWIRE
    07 Nov 2025
    Share Share
    Surrozen To Present at Upcoming Healthcare Investor Conference
    Surrozen To Present at Upcoming Healthcare Investor Conference

    05 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/05/3181925/0/en/Surrozen-to-Present-at-Upcoming-Healthcare-Investor-Conference.html

    GLOBENEWSWIRE
    05 Nov 2025
    Share Share
    Surrozen Reports Inducement Grants Under Nasdaq LR 5635(c)(4)
    Surrozen Reports Inducement Grants Under Nasdaq LR 5635(c)(4)

    04 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/04/3144985/0/en/Surrozen-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    04 Sep 2025
    Share Share
    Surrozen to Present at Upcoming Healthcare Investor Conference
    Surrozen to Present at Upcoming Healthcare Investor Conference

    03 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/03/3144065/0/en/Surrozen-to-Present-at-Upcoming-Healthcare-Investor-Conference.html

    GLOBENEWSWIRE
    03 Sep 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search